My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 431

    1.

    Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity.

    Kapoor D, Aldred H, Clark S, Channer KS, Jones TH.

    Diabetes Care. 2007 Apr;30(4):911-7.PMID: 17392552 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes.

    Kapoor D, Clarke S, Channer KS, Jones TH.

    Int J Androl. 2007 Dec;30(6):500-7.PMID: 18028199 [PubMed - indexed for MEDLINE]Related articles

    3.

    Statin therapy is associated with lower total but not bioavailable or free testosterone in men with type 2 diabetes.

    Stanworth RD, Kapoor D, Channer KS, Jones TH.

    Diabetes Care. 2009 Apr;32(4):541-6. Epub 2008 Dec 29.PMID: 19114614 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The pituitary-gonadal axis and health in elderly men: a study of men born in 1913.

    Tibblin G, Adlerberth A, Lindstedt G, Björntorp P.

    Diabetes. 1996 Nov;45(11):1605-9.PMID: 8866567 [PubMed - indexed for MEDLINE]Related articles

    5.

    Rosiglitazone increases bioactive testosterone and reduces waist circumference in hypogonadal men with type 2 diabetes.

    Kapoor D, Channer KS, Jones TH.

    Diab Vasc Dis Res. 2008 Jun;5(2):135-7.PMID: 18537102 [PubMed - indexed for MEDLINE]Related articles

    6.

    Is there a relationship between sex hormones and erectile dysfunction? Results from the Massachusetts Male Aging Study.

    Kupelian V, Shabsigh R, Travison TG, Page ST, Araujo AB, McKinlay JB.

    J Urol. 2006 Dec;176(6 Pt 1):2584-8.PMID: 17085164 [PubMed - indexed for MEDLINE]Related articles

    7.

    The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes.

    Kapoor D, Clarke S, Stanworth R, Channer KS, Jones TH.

    Eur J Endocrinol. 2007 May;156(5):595-602.PMID: 17468196 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study.

    Yeap BB, Chubb SA, Hyde Z, Jamrozik K, Hankey GJ, Flicker L, Norman PE.

    Eur J Endocrinol. 2009 Oct;161(4):591-8. Epub 2009 Aug 6.PMID: 19661128 [PubMed - indexed for MEDLINE]Related articles

    9.

    Steroids in adult men with type 1 diabetes: a tendency to hypogonadism.

    van Dam EW, Dekker JM, Lentjes EG, Romijn FP, Smulders YM, Post WJ, Romijn JA, Krans HM.

    Diabetes Care. 2003 Jun;26(6):1812-8.PMID: 12766115 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes.

    Stanworth RD, Kapoor D, Channer KS, Jones TH.

    Eur J Endocrinol. 2008 Dec;159(6):739-46. Epub 2008 Sep 19.PMID: 18805913 [PubMed - indexed for MEDLINE]Related articles

    11.

    Visceral and subcutaneous adipose tissue assessed by magnetic resonance imaging in relation to circulating androgens, sex hormone-binding globulin, and luteinizing hormone in young men.

    Nielsen TL, Hagen C, Wraae K, Brixen K, Petersen PH, Haug E, Larsen R, Andersen M.

    J Clin Endocrinol Metab. 2007 Jul;92(7):2696-705. Epub 2007 Apr 10.PMID: 17426100 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Testosterone concentration in young patients with diabetes.

    Chandel A, Dhindsa S, Topiwala S, Chaudhuri A, Dandona P.

    Diabetes Care. 2008 Oct;31(10):2013-7. Epub 2008 Jul 23.PMID: 18650372 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    [Changes in sexual hormones in a male population over 50 years of age. Frequency of low testosterone levels and risk factors]

    Martínez Jabaloyas JM, Queipo Zaragoza A, Ferrandis Cortes C, Queipo Zaragoza JA, Gil Salom M, Chuan Nuez P.

    Actas Urol Esp. 2008 Jun;32(6):603-10. Spanish. PMID: 18655343 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Functional testosterone: biochemical assessment of hypogonadism in men--report from a multidisciplinary workshop hosted by the Ontario Society of Clinical Chemists.

    Collier CP, Clark AF, Bain J, Godwin M, Hudson RW, Lepage R, Morales A, Moses G, Tremblay RR, Vandenberghe H.

    Aging Male. 2007 Dec;10(4):211-6.PMID: 18033630 [PubMed - indexed for MEDLINE]Related articles

    15.

    Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III).

    Selvin E, Feinleib M, Zhang L, Rohrmann S, Rifai N, Nelson WG, Dobs A, Basaria S, Golden SH, Platz EA.

    Diabetes Care. 2007 Feb;30(2):234-8. Erratum in: Diabetes Care. 2007 Jun;30(6):1683. PMID: 17259487 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat.

    Tsai EC, Matsumoto AM, Fujimoto WY, Boyko EJ.

    Diabetes Care. 2004 Apr;27(4):861-8.PMID: 15047639 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1000 mg IM--Nebido).

    Moisey R, Swinburne J, Orme S.

    Clin Endocrinol (Oxf). 2008 Oct;69(4):642-7. Epub 2008 Apr 3.PMID: 18394021 [PubMed - indexed for MEDLINE]Related articles

    18.

    Total but not bioavailable testosterone is a predictor of central adiposity in postmenopausal women.

    Goodman-Gruen D, Barrett-Connor E.

    Int J Obes Relat Metab Disord. 1995 May;19(5):293-8.PMID: 7647819 [PubMed - indexed for MEDLINE]Related articles

    19.

    Hypogonadism is associated with overt depression symptoms in men with erectile dysfunction.

    Makhlouf AA, Mohamed MA, Seftel AD, Niederberger C.

    Int J Impot Res. 2008 Mar-Apr;20(2):157-61. Epub 2007 Aug 16. Erratum in: Int J Impot Res. 2008 Mar-Apr;20(2):229. Neiderberger, C [corrected to Niederberger, C]. PMID: 17703222 [PubMed - indexed for MEDLINE]Related articles

    20.

    High prevalence of hypogonadotropic hypogonadism in men referred for obesity treatment.

    Hofstra J, Loves S, van Wageningen B, Ruinemans-Koerts J, Jansen I, de Boer H.

    Neth J Med. 2008 Mar;66(3):103-9.PMID: 18349465 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity